Pharmacokinetic Considerations in Amputees.
Elbarbry F, Nguyen V, Kawaguchi-Suzuki M.
J Pharm Pract. 2021 Oct;34(5):794-799. doi: 10.1177/0897190020942659. Epub 2020 Jul 29.
Influence of the microbiota and probiotics in obesity.
Fontané L, Benaiges D, Goday A, Llauradó G, Pedro-Botet J.
Clin Investig Arterioscler. 2018 Nov-Dec;30(6):271-279. doi: 10.1016/j.arteri.2018.03.004. Epub 2018 May 25.
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist.
Benichou O, Coskun T, Gonciarz MD, Garhyan P, Adams AC, Du Y, Dunbar JD, Martin JA, Mather KJ, Pickard RT, Reynolds VL, Robins DA, Zvada SP, Emmerson PJ.
Cell Metab. 2023 Feb 7;35(2):274-286.e10. doi: 10.1016/j.cmet.2022.12.011. Epub 2023 Jan 10.
Activity-balanced GLP-1/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates.
Zhang Y, Zhao X, Dong X, Zhang Y, Zou H, Jin Y, Guo W, Zhai P, Chen X, Kharitonenkov A.
Cell Metab. 2023 Feb 7;35(2):287-298.e4. doi: 10.1016/j.cmet.2023.01.001. Epub 2023 Jan 26.
Sugar-sweetened beverage consumption and weight gain in children and adults: a systematic review and meta-analysis of prospective cohort studies and randomized controlled trials.
Nguyen M, Jarvis SE, Tinajero MG, Yu J, Chiavaroli L, Mejia SB, Khan TA, Tobias DK, Willett WC, Hu FB, Hanley AJ, Birken CS, Sievenpiper JL, Malik VS.
Am J Clin Nutr. 2023 Jan;117(1):160-174. doi: 10.1016/j.ajcnut.2022.11.008. Epub 2022 Dec 20.
Physical Activity and Excess Body Weight and Adiposity for Adults. American College of Sports Medicine Consensus Statement.
Jakicic JM, Apovian CM, Barr-Anderson DJ, Courcoulas AP, Donnelly JE, Ekkekakis P, Hopkins M, Lambert EV, Napolitano MA, Volpe SL.
Med Sci Sports Exerc. 2024 Oct 1;56(10):2076-2091. doi: 10.1249/MSS.0000000000003520.
Anesthetizing the obese.
Green B, McLeay SC.
Anesth Analg. 2011 Jul;113(1):1-3. doi: 10.1213/ANE.0b013e318212eae8.
Associations of obesity indices change with cardiovascular outcomes: a dose-response meta-analysis.
Wang L, Ding H, Deng Y, Huang J, Lao X, Wong MCS.
Int J Obes (Lond). 2024 May;48(5):635-645. doi: 10.1038/s41366-024-01485-8. Epub 2024 Feb 9.
Considerations for the development of guidance on dose level selection for developmental and reproductive toxicity studies.
Lewis RW, Andrus AK, Arroyo J, Brescia S, Botham PA, Corvaro M, Daston GP, Hofmann T, Rodriguez C, Sewell F, van Ravenzwaay B, Wiench K, Marty S.
Regul Toxicol Pharmacol. 2024 Mar;148:105585. doi: 10.1016/j.yrtph.2024.105585. Epub 2024 Feb 24.
Dose-response trend tests for tumorigenesis, adjusted for body weight.
Gaylor DW, Kodell RL.
Toxicol Sci. 1999 Jun;49(2):318-23. doi: 10.1093/toxsci/49.2.318.
